Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration:
2020
ObjectiveTo compare the efficacy of ranibizumab plus fufang xueshuantong capsule (cFXST) with the efficacy of ranibizumab alone in treatment of exudative age-related macular degeneration.MethodsThi...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
36
References
0
Citations
NaN
KQI